Finding out that you are going to have a baby may be one of the happiest days of your life. Sadly for one family in New York, the joy quickly turned to fear and uncertainty when they found out their baby would be born with a complex form of congenital heart disease. Having already diagnosed the condition in the womb, the doctors at NewYork-Presbyterian/Morgan Stanley Children's Hospital had time to plan how they would save the baby's life before it even began with the support of 3D printing and Materialise's Mimics Innovation Suite of software.

Creating a Complex Orbital Floor Reconstruction with the Mimics® Innovation Suite

Collaboration aims to bring the solutions offered by 3D printed planning tools to cardiovascular specialists in China

Consensus to use Materialise's ACO Hip Guide System, allowing surgeons working with Consensus' hip implants to plan their surgeries in 3D and use 3D printed patient-specific guides

SmarTech has estimated the number of installed polymer printers in dental applications to outnumber that of metal printers at a ratio of 19:1 today - this will remain consistent throughout the next decade despite metal printer growth of 16 percent CAGR over the next ten years.

This Version of the ReWalk Personal Exoskeleton Offers Users the Fastest Walking Speed, Most Natural Gait, and the Most Precise Fit of Any Exoskeleton

By Allison Mills

The printer looks like a toaster oven with the front and sides removed. Its metal frame is built up around a stainless steel circle lit by an ultraviolet light. Stainless steel hydraulics and thin black tubes line the back edge, which lead to an inner, topside box made of red plastic. In front, the metal is etched with the red Bio Bot logo. All together, the gray metal frame is small enough to fit on top of an old-fashioned school desk, but nothing about this 3D printer is old school. In fact, the tissue-printing machine is more like a sci-fi future in the flesh—and it has very real medical applications.

Poietis, first French bioprinting company today announced the issuance by the American Patent Office (USPTO) and the Japanese Office (JPO) of two patents covering its 3D laser assisted bioprinting technology. " The issuance of these patents both in the USA and Japan is very good news. These decisions lays the foundation for future industrial exploitation in these two important countries, that represent together a very large part of the regenerative medicine market " said Bruno Brisson, Poietis co-founder and Director of Business Development.